Neil Chatterji
Stock Analyst at B. Riley Securities
(1.56)
# 3,520
Out of 5,113 analysts
19
Total ratings
29.41%
Success rate
2.77%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $14.20 | +97.18% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $11.64 | +11.68% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $65.10 | -23.20% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $0.81 | +829.94% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $25.06 | -28.17% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $5.63 | -20.00% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.19 | +194.12% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.59 | +112.36% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $4.43 | +114.45% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $14.20
Upside: +97.18%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $11.64
Upside: +11.68%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $65.10
Upside: -23.20%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $0.81
Upside: +829.94%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $25.06
Upside: -28.17%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $5.63
Upside: -20.00%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.19
Upside: +194.12%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.59
Upside: +112.36%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $4.43
Upside: +114.45%